BURLINGTON, Mass., Oct. 19 /PRNewswire-FirstCall/ -- LeMaitre Vascular, Inc. announced today the pricing of its initial public offering of 5,500,000 shares of its common stock at a price to the public of $7.00 per share. All of the shares to be sold in the offering are to be sold by LeMaitre, and the net proceeds of this offering are intended to repay a portion of the LeMaitre’s outstanding indebtedness, to finance working capital needs, including the hiring of additional sales personnel, the funding of clinical studies and the expansion of manufacturing and research and development capabilities, and for general corporate purposes. LeMaitre has granted the underwriters an option to purchase an additional 825,000 shares of common stock at the initial public offering price to cover over-allotments, if any. The shares will trade on the Nasdaq Global Market under the symbol “LMAT.”
The offering is being made through an underwriting syndicate led by Goldman, Sachs & Co. as sole book runner for the offering. CIBC World Markets, Cowen and Company and Thomas Weisel Partners LLC are acting as co-managers.
Copies of the final prospectus relating to the offering may be obtained from Goldman, Sachs & Co., Prospectus Department, 85 Broad Street, New York, New York 10004, which can be reached by fax at 212-902-9316 or by email at prospectus-ny@ny.email.gs.com.
A registration statement relating to these securities was declared effective by the Securities and Exchange Commission on October 18, 2006. This press release shall not constitute an offer to sell or a solicitation of an offer to buy, nor will there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
About LeMaitre Vascular
LeMaitre Vascular develops, manufactures and markets medical devices for the treatment of peripheral vascular disease. The company’s principal executive offices are located at 63 Second Avenue, Burlington, Massachusetts 01803.
Contacts Sandra Millar (Office: 781.221.2266) Media Relations, LeMaitre Vascular, Inc. Aaron Grossman (Office: 781.221.2266) Investor Relations, LeMaitre Vascular, Inc
LeMaitre Vascular
CONTACT: Sandra Millar, Media Relations, +1-781-221-2266, or AaronGrossman, Investor Relations, +1-781-221-2266, both of LeMaitre Vascular,Inc
Web site: http://www.lemaitre.com//
